Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies

被引:91
|
作者
Benoit, DD
Hoste, EA
Depuydt, PO
Offner, FC
Lameire, NH
Vandewoude, KH
Dhondt, AW
Noens, LA
Decruyenaere, JM
机构
[1] Ghent Univ Hosp, Med Intens Care Unit, Dept Internal Med, B-9000 Ghent, Belgium
[2] Ghent Univ Hosp, Intens Care Med Div, B-9000 Ghent, Belgium
[3] Ghent Univ Hosp, Div Hematol, B-9000 Ghent, Belgium
[4] Ghent Univ Hosp, Div Renal, B-9000 Ghent, Belgium
关键词
acute renal failure; haematological malignancy; infection; intensive care unit; renal replacement therapy;
D O I
10.1093/ndt/gfh637
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Starting renal replacement therapy (RRT) for acute renal failure in critically ill patients with haematological malignancies is controversial because of the poor outcome and high costs. The aim of this study was to compare the outcome between critically ill medical patients with and without haematological malignancies who received RRT for acute renal failure. Methods. We retrospectively collected data on all consecutive patients who received RRT for acute renal failure at the Medical Intensive Care Unit (ICU) of a University Hospital between 1997 and 2002, and assessed the impact of the presence of a haematological malignancy on the survival within 6 months after ICU admission by Cox proportional hazard models. Results. Fifty of the 222 (22.5%) consecutive patients with haematological malignancies admitted to the ICU over the study period received RRT for acute renal failure compared with 248 of the 4293 (5.8%) patients without haematological malignancies (P < 0.001). Among patients who received RRT, those with haematological malignancies had higher crude ICU (79.6 vs 55.7%, P=0.002) and in-hospital (83.7 vs 66.1%, P = 0.016) mortality rates, and a higher mortality at 6 months (86 vs 72%, P = 0.018) by Kaplan-Meier estimates compared with those without haematological malignancies. However, after adjustment for the severity of illness and the duration of hospitalization before ICU admission, haematological malignancy by itself was no longer associated with a higher risk of death (hazard ratio 1.04; 95% confidence interval, 0.73-1.54, P = 0.78). Conclusions. Medical ICU patients with haematological malignancies have a higher rate of occurrence of acute renal failure treated with RRT and a higher mortality, compared with those without haematological malignancies. However, the presence of a haematological malignancy by itself is not a reason to withhold RRT in medical ICU patients with acute renal failure.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 50 条
  • [21] Preemptive renal replacement therapy in critically ill patients?
    Meersch, Melanie
    Zarbock, Alexander
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (16)
  • [22] Continuous renal replacement therapy in critically ill patients
    Ronco, C
    Bellomo, R
    Ricci, Z
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 67 - 72
  • [23] Renal long-term outcome of critically ill COVID-19 patients with acute kidney failure and continuous renal replacement therapy
    Melero, Rosa
    Mijaylova, Antonia
    Rodriguez-Benitez, Patrocinio
    Macias, Nicolas
    Aragoncillo, Ines
    Luisa Rodriguez-Ferrero, Maria
    Garcia-Prieto, Ana
    Bascunana, Arturo
    Acosta, Adriana
    Gonzalez-Rojas, Angela
    Munoz de Morales, Alejandra
    Carbayo, Javier
    Sanchez-Camara, Luis
    Verdalles, Ursula
    Abad, Soraya
    Vega, Almudena
    Verde, Eduardo
    Arroyo, David
    Perez de Jose, Ana
    Pinero, Patricia
    Cedeno, Jamil
    Anaya, Fernando
    Antonio Rengel, Manuel
    Barraca, Daniel
    Olmedo, Maria
    Goicoechea, Marian
    CLINICAL KIDNEY JOURNAL, 2021, 14 (11) : 2449 - 2450
  • [24] Acute renal failure in critically ill surgical patients: Persistent lethality despite new modes of renal replacement therapy
    Eachempati, Soumitra R.
    Wang, John C. L.
    Hydo, Lynn J.
    Shou, Jian
    Barie, Philip S.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (05): : 987 - 993
  • [25] The Protein Equivalent of Nitrogen Appearance in Critically Ill Acute Renal Failure Patients Undergoing Continuous Renal Replacement Therapy
    Ganesan, Muthusamy V.
    Annigeri, Rajeev A.
    Shankar, Bhuvaneswari
    Rao, Budithi Subba
    Prakash, Kowdle C.
    Seshadri, Rajagopalan
    Mani, Muthu Krishna
    JOURNAL OF RENAL NUTRITION, 2009, 19 (02) : 161 - 166
  • [26] Antibiotic Therapy in the Critically Ill with Acute Renal Failure and Renal Replacement Therapy: A Narrative Review
    Corona, Alberto
    Cattaneo, Dario
    Latronico, Nicola
    ANTIBIOTICS-BASEL, 2022, 11 (12):
  • [27] Outcome of critically ill patients with acute renal failure and multiple organ failure treated with continuous venovenous haemodiafiltration
    Sirvent, J. M.
    Valles, M.
    Navas, E.
    Calabia, J.
    Ortiz, P.
    Bonet, A.
    MEDICINA INTENSIVA, 2010, 34 (02) : 95 - 101
  • [28] Timing of renal replacement therapy in critically ill patients with acute kidney injury
    Meersch, Melanie
    Schmidt, Christoph
    Schmidt, Joachim
    Zarbock, Alexander
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (18)
  • [29] 'TIMING OF RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS WITH ACUTE KIDNEY INJURY
    Avila, R.
    Carrizo, N.
    Zuchella, C.
    Cursio, P.
    Ponzo, I.
    Fernandez, A.
    INTENSIVE CARE MEDICINE, 2014, 40 : S57 - S57
  • [30] Timing of renal replacement therapy in critically ill patients with acute kidney injury
    Bouman, Catherine S. C.
    Straaten, Heleen M. Oudemans-van
    CURRENT OPINION IN CRITICAL CARE, 2007, 13 (06) : 656 - 661